DataM Intelligence, a global market intelligence and consulting firm, has released it’s latest analysis showing the Global Choline Supplements Market reached US$ 625.11 Million in 2025 and it is expected to reach up to US$ 1,262.09 Million in 2035, expanding at a CAGR of 7.4% during 2026-2035. Rising awareness of cognitive health, increasing focus on prenatal nutrition, expanding e-commerce supplement sales, and growing adoption of preventive healthcare practices will continue to drive the global choline supplements market. Demand is being supported by increasing recognition of choline’s role in brain development, memory functions, liver health and maternal nutrition. According to the estimates of nearly 90-95% of pregnant women consume insufficient choline, creating significant opportunities for prenatal supplementation products. Furthermore, premium ingredients such as Alpha-GPC and CDP-Choline (Citicoline) are expected to witness strong growth as consumers increasingly prefer science-backed cognitive health solutions, while expanding online retail channels and direct-to-consumer supplement brands continue to improve product accessibility and consumer awareness worldwide.
Increasing awareness of prenatal nutrition, growing demand for cognitive health supplements, expanding e-commerce channels, and rising adoption of preventive healthcare are driving growth in the global choline supplements market. Regulatory guidance on adequate choline intake, growing emphasis on maternal and cognitive health, and increasing demand for science-backed nutritional products are further strengthening market expansion.
Request for Exclusive Sample of This Report: https://www.datamintelligence.com/download-sample/choline-supplements-market
Key Takeaways
- Premium ingredients such as Alpha-GPC and CDP-Choline (Citicoline) are expected to witness faster growth due to increasing demand for science-backed cognitive health solutions.
- Brain health and prenatal & maternal nutrition remain the leading application segments, supported by growing consumer focus on cognitive wellness and fetal development.
- NIH review found only 40% of 188 prenatal supplements contained choline, with an average of only 25 mg per serving.
- North America currently holds the largest market with 39.9% market share, while Asia-Pacific is expected to witness strong growth with 24.9% market share, driven by increasing health awareness and supplement adoption.
- Pregnant and Lactating Women segment projected to exceed 11% annual growth by 2035, reflecting rising prenatal supplementation
Rising Prenatal Nutrition Awareness Boosts Choline Supplementation Among Pregnant Women
Increasing awareness of fetal brain development, growing recognition of maternal nutritional deficiencies and expanding healthcare recommendations are driving demand for prenatal choline supplements globally. Healthcare professionals and nutrition organizations are increasingly emphasizing the importance of adequate choline intake during pregnancy due to its role in fetal brain development, neural tube formation, and cognitive health outcomes.
According to the National Institutes of Health (NIH) Office of Dietary Supplements, pregnant women require 450 mg of choline per day, yet only 7.7% of pregnant women in the US meet the recommended intake levels through diet. Furthermore, approximately 90-95% of pregnant women consume insufficient amounts of choline, creating a significant nutritional gap and increasing demand with a 36% higher risk of neural tube defects and a 33% higher risk of spina bifida in offspring. As a result, supplement manufacturers are increasingly developing prenatal formulations containing choline alongside DHA, folate and omega-3 fatty acids to support maternal and infant health outcomes.
Alpha-GPC Segment Gains Premium Positioning Through Cognitive Health Demand and Advanced Supplement Formulations
Alpha-GPC is emerging as one of the fastest-growing ingredient segments within the global choline supplements market, driven by increasing consumer interest in cognitive health, memory enhancement, and is premium nootropic products. The segment was valued at US$ 105.44 million in 2025 and is projected to reach US$ 281.66 million by 2035, reflecting strong demand for highly bioavailable choline ingredients. Growing adoption of brain health supplements among students, professionals, athletes, and aging populations is supporting the expansion of Alpha-GPC based formulations across capsules, powders, gummies and functional beverages. In November 2025, Chemi Nutra, a US-based privately held nutraceutical company, expanded access to it’s AlphaSize® Alpha-GPC ingredient through new manufacturing partnerships, strengthening supply chain capabilities and improving availability for supplement manufacturers.
North America Maintains Market Leadership Through Strong Consumer Awareness and Advanced Supplements Ecosystems
North America continues to hold a leading position in the global choline supplements market, supported by high dietary supplement adoption, increasing awareness of cognitive health, and growing emphasis on prenatal nutrition. The region benefits from a well-established nutraceutical industry, strong healthcare professional engagement, and expanding direct-to-consumer and e-commerce channels. According to the report, North America accounted for 39.9% of the global choline supplements market in 2025, making it the largest regional market. The region is also witnessing increasing demand for premium choline ingredients such as Alpha-GPC, Citicoline, and Phosphatidylcholine, driven by consumer preference for science-backed cognitive wellness and maternal health products.
The North American market was valued at US$ 249.36 million in 2025 and is projected to reach US$ 508.03 million by 2035, supported by rising adoption of prenatal supplements and healthy aging products. The United States remains the primary growth engine due to strong consumer spending on nutritional supplements and increasing awareness of choline deficiency among pregnant women. Furthermore, the rapid expansion of online supplement retailing, growing preventive healthcare trends, and continuous product innovation by major supplement brands are reinforcing North America's position as the leading regional market for choline supplements.
Competitive Landscape and Strategic Developments
The global choline supplements market is highly competitive due to increasing consumer demand for cognitive health, prenatal nutrition, healthy aging, and preventive healthcare products. Market participants are focusing on product innovation, premium ingredient formulations, clinical validation, and expanding direct-to-consumer and e-commerce channels to strengthen their market presence. The top identified players account for a relatively small share of total revenue. In 2025, Nestlé held approximately 7.1% market share, followed by NOW Foods (6.1%), Jarrow Formulas (4.1%), Thorne HealthTech (2.8%), and Life Extension (2.7%), while other market participants collectively accounted for over 77% of the market, highlighting significant opportunities for product differentiation and brand expansion. Companies are enhancing their market position through new product launches, strategic partnerships, healthcare professional collaborations, and investments in advanced choline ingredients such as Alpha-GPC, Citicoline, and Phosphatidylcholine to address growing demand for science-backed nutritional supplements.
Key Developments:
- In December 2025, NNB Nutrition launched BioVantage, an advanced nutrient delivery technology platform designed to improve the bioavailability, stability, and sustained release of dietary supplement ingredients. The platform combines liposomal delivery systems and beadlet technologies to enhance nutrient absorption and formulation performance across various supplement categories, including cognitive health products that may incorporate choline-based ingredients. This innovation supports the development of next-generation nutritional supplements by enabling more effective delivery of active compounds and improving consumer outcomes.
- In July 2025, SpringHealth launched BloomWell, a maternal wellness supplement range designed to support women from preconception through pregnancy and postpartum care. The product line includes specialized formulations enriched with essential nutrients such as choline and folic acid to support fetal brain development, maternal health, and early childhood nutrition during the first 1,000 days. The launch strengthens SpringHealth’s presence in the maternal nutrition segment and addresses the growing demand for scientifically formulated prenatal and postnatal supplements.
- In March 2026, SmartyPants Vitamins launched its new OB-GYN co-developed Prenatal Plus Multivitamin Capsules, formulated to support fetal brain and spinal cord development during pregnancy. The product delivers 480 mg of choline per daily serving, alongside essential prenatal nutrients, addressing the growing awareness of choline’s importance in maternal and infant health. The launch expands SmartyPants’ prenatal nutrition portfolio and strengthens its position in the rapidly growing maternal wellness and choline supplement segments.
Leading Company Profiles and Strategic Developments
NOW Foods (US)
In the global choline supplements market, NOW Foods accounted for approximately 6.1% market share in 2025, making it one of the leading branded participants in an otherwise fragmented market. NOW Foods is a leading U.S.-based manufacturer of dietary supplements, natural health products, sports nutrition ingredients, and functional foods. The company offers a broad portfolio of nutritional supplements, including choline-based products such as Choline & Inositol capsules and liquid formulations, catering to consumers seeking cognitive health, liver support, and overall wellness benefits. NOW Foods is strategically positioned to benefit from the growth of the global choline supplements market, which is projected to increase from US$625.1 million in 2025 to US$1.26 billion by 2035, at a CAGR of 7.4%. NOW Foods has established a strong presence in the global dietary supplements industry through its focus on product quality, affordability, and scientific formulation.
In April 2026, NOW Foods launched Vitamin C Gummies and Vitamin D3 Gummies, entering the growing gummy supplement category to meet rising consumer demand for convenient and enjoyable nutritional products while expanding its dietary supplements portfolio.
Analyst Opinion
The global choline supplements market is evolving from a general wellness category into a more clinically driven nutrition segment, with prenatal nutrition and cognitive health emerging as the most attractive growth areas. Prenatal supplementation is expected to remain a key demand driver, as approximately 90–95% of pregnant women fail to meet adequate choline intake levels and only 7.7% achieve recommended intake through diet alone, creating a significant and persistent nutritional gap. Increasing clinical evidence supporting choline's role in fetal brain development, neural function, and maternal health is encouraging healthcare professionals and supplement manufacturers to promote higher-dose prenatal formulations. At the same time, consumer demand is shifting toward premium cognitive-health ingredients such as Alpha-GPC and Citicoline, which offer stronger scientific validation and are increasingly used in memory, focus, mental performance, and healthy aging applications.
Pregnant & Lactating Women – Key Revenue-Contributing Segment
The global choline supplements market is shifting from general nutritional supplementation toward targeted health outcomes with the market grow from US$ 625.11 million in 2025 to US$ 1,262.09 million by 2035, at a CAGR of 7.4%.
Pregnant and lactating women represent the strongest buyer segment due to 90–95% of pregnant women consuming insufficient choline, creating a significant nutritional gap.
Recommended intake reaches 450 mg/day during pregnancy and 550 mg/day during lactation.
Adults Seeking Preventive Brain Health and Cognitive Function Support
Adults increasingly purchase choline supplements to support memory, focus, productivity, and long-term brain health. Brain Health is the largest application segment, generating approximately US$ 173.5 million in sales in 2025.
Healthy Aging and Longevity Consumers Prioritizing Brain and Metabolic Health
The aging population is increasingly adopting choline supplements to maintain cognitive function and independence. Healthy Aging & Longevity applications generated approximately US$ 82.7 million in 2025.
The geriatric segment is forecast to grow steadily with annual growth rates exceeding 9.3% by 2035.
Health-Conscious Consumers Focused on Preventive Nutrition and Long-Term Wellness
Consumers focused on preventive healthcare increasingly view choline as an essential daily nutrient. Recommended intake levels are 550 mg/day for men and 425 mg/day for women.
75% of U.S. adults used dietary supplements in 2024, while 91% consider supplements essential to health routines.
Athletes and Fitness Enthusiasts Seeking Enhanced Physical and Cognitive Performance
Athletes and active consumers are increasingly exploring choline supplementation for neuromuscular performance and endurance support. This accounted for approximately US$ 47 million in 2025.
Growing adoption of Alpha-GPC-based formulations is strengthening demand among fitness-focused consumers.
